OFFICIAL CORE POWER PEPTIDES™ STOREFree shipping on US orders over $300OFFICIAL · AUTHENTIC · SINCE 2024Lab-tested 99%+ purity100% Made in the USAOFFICIAL CORE POWER PEPTIDES™ STOREDiscreet packagingOFFICIAL · AUTHENTIC · SINCE 2024Fast 2–5 day US shipping
OFFICIAL CORE POWER PEPTIDES™ STOREFree shipping on US orders over $300OFFICIAL · AUTHENTIC · SINCE 2024Lab-tested 99%+ purity100% Made in the USAOFFICIAL CORE POWER PEPTIDES™ STOREDiscreet packagingOFFICIAL · AUTHENTIC · SINCE 2024Fast 2–5 day US shipping

Buy CJC-1295 Without DAC: Research Guide and Ipamorelin Blend

Table of Contents

Buy CJC-1295 Without DAC: Research Guide and Ipamorelin Blend

CJC-1295 Without DAC (Modified GRF 1-29) is a synthetic 30-amino acid growth hormone releasing hormone analog that stimulates pituitary GH secretion in a short-acting pulsatile pattern. Its shorter half-life (~30–60 minutes vs. 6–8 days for the DAC-modified version) makes it particularly suitable for research protocols that require mimicking the physiological pulsatility of endogenous GH secretion rather than continuous sustained elevation.

Combined with ipamorelin, CJC-1295 Without DAC represents the most widely used GH secretagogue dual-pathway stack in preclinical research — with GHRHR activation (CJC-1295) and GHS-R1a activation (ipamorelin) producing synergistic GH responses 5–10× above baseline in rodent models.

Mechanism of Action

  • GHRHR Agonism: Directly activates growth hormone-releasing hormone receptors on pituitary somatotrophs
  • cAMP Cascade: GHRHR activation increases intracellular cAMP and PKA, triggering GH synthesis and pulse release
  • Pulsatility Preservation: Short half-life (without DAC) allows GH to return to baseline between doses, mimicking natural secretion rhythms
  • GHRH + GHS-R Synergy: CJC-1295 + ipamorelin co-activation produces supra-additive GH release via simultaneous GHRH and ghrelin pathway stimulation

Research Data

  • Dose-dependent GH elevation: 1–100 µg/kg produces 2–10× baseline GH in rodents
  • Peak GH response 15–30 min post-administration, return to baseline by 2–3 hours
  • Combination with ipamorelin: GH response 5–10× greater than either compound alone
  • No tachyphylaxis in twice-daily dosing protocols over 4-week periods
  • IGF-1 normalization in GH-deficient rodent models with daily dosing

CJC-1295 With vs. Without DAC — Quick Reference

Parameter Without DAC With DAC
Half-life 30–60 min 6–8 days
Dosing frequency 1–3× daily 1× weekly
GH pattern Pulsatile (physiological) Continuous elevation
Research use Acute/combination studies Chronic protocol studies
CJC-1295 Research Products

Research Disclaimer: This product is sold strictly for in vitro research and laboratory use only. Not for human consumption. Not medical advice.

Leave a Reply

Your email address will not be published. Required fields are marked *